Improving brain penetration of kinase inhibitors in lung cancer patients with oncogene dependency
Ann Oncol
.
2017 Feb 1;28(2):196-198.
doi: 10.1093/annonc/mdw553.
Authors
J Remon
1
,
J C Soria
1
2
Affiliations
1
Department of Thoracic Medical Oncology, Gustave Roussy, Villejuif, France.
2
Université Paris-Sud, Paris-Saclay, Orsay, Francee.
PMID:
28426099
DOI:
10.1093/annonc/mdw553
No abstract available
Publication types
Editorial
Comment
MeSH terms
Brain / drug effects
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Oncogenes / drug effects
Protein Kinase Inhibitors
Substances
Protein Kinase Inhibitors